Open access

Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies
Jason Cham, Li Zhang, Serena Kwek, Alan Paciorek, Tao He, Grant Fong, David Y Oh, Lawrence Fong

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000368; DOI: 10.1136/jitc-2019-000368
Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model
Jiaji Mao, Minghui Cao, Fang Zhang, Jingzhong Zhang, Xiaohui Duan, Liejing Lu, Zehong Yang, Xiang Zhang, Wangshu Zhu, Qinyuan Zhang, Zhe Wang, Jun Shen

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000164; DOI: 10.1136/jitc-2019-000164
Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay
Diego A Lema, Ewa Jankowska-Gan, Nan Sethakorn, William Burlingham, Ticiana Leal

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000152; DOI: 10.1136/jitc-2019-000152
Correction: Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e0370-6corr1; DOI: 10.1136/jitc-2020-0370-6corr1
CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
Laura Agresta, Maria Lehn, Kristin Lampe, Rachel Cantrell, Cassandra Hennies, Sara Szabo, Trisha Wise-Draper, Laura Conforti, Kasper Hoebe, Edith M Janssen

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000245; DOI: 10.1136/jitc-2019-000245
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
Pierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, Rocco Giannicola, Rita Agostino, Nicoletta Staropoli, Alessandra Strangio, Teresa Del Giudice, Valerio Nardone, Maria Altomonte, Pierpaolo Pastina, Paolo Tini, Antonia Consuelo Falzea, Natale Imbesi, Valentina Arcati, Giuseppa Romeo, Daniele Caracciolo, Amalia Luce, Michele Caraglia, Antonio Giordano, Luigi Pirtoli, Alois Necas, Evzen Amler, Vito Barbieri, Pierfrancesco Tassone, Pierosandro Tagliaferri

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000733; DOI: 10.1136/jitc-2020-000733
NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8⁺ T cell responses capable of curing multi-focal cancer
Joshua M Walker, Annah S Rolig, Deborah H Charych, Ute Hoch, Melissa J Kasiewicz, Daniel C Rose, Michael J McNamara, Ian F Hilgart-Martiszus, William L Redmond

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000464; DOI: 10.1136/jitc-2019-000464
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Klümper, Damian J Ralser, Emma Grace Bawden, Jenny Landsberg, Romina Zarbl, Glen Kristiansen, Marieta Toma, Manuel Ritter, Michael Hölzel, Jörg Ellinger, Dimo Dietrich

Journal for ImmunoTherapy of Cancer Mar 2020, 8 (1) e000552; DOI: 10.1136/jitc-2020-000552
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Sandra Demaria, Chandan Guha, Jonathan Schoenfeld, Zachary Morris, Arta Monjazeb, Andrew Sikora, Marka Crittenden, Stephen Shiao, Samir Khleif, Seema Gupta, Silvia Chiara Formenti, Bhadrasain Vikram, C Norman Coleman, Mansoor M Ahmed

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002038; DOI: 10.1136/jitc-2020-002038
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
Georgia M Beasley, Smita K Nair, Norma E Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin-Ho Jung, Darell D Bigner, Andrea True Kelly, Matthias Gromeier, April KS Salama

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002203; DOI: 10.1136/jitc-2020-002203

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages